Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
MASKINVEST.NS Stock Summary
Top 10 Correlated ETFs
MASKINVEST.NS
In the News
MASKINVEST.NS Financial details
Company Rating
-
Market Cap
206.28M
Income
589.85K
Revenue
3.21M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
3
Optionable
No
Shortable
Yes
Earnings
06 Feb 2024
P/E
364.83
Forward P/E
-
PEG
1.94
P/S
64.29
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.2
EPS next Y
-
EPS next Q
-
EPS this Y
1800%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
43.89%
Revenue last 5Y
12.92%
Revenue Q/Q
-36.97%
EPS Q/Q
-34.57%
-
-
-
-
SMA20
27.18%
SMA50
-11%
SMA100
10.44%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
53%
Oper. Margin
34%
Profit Margin
18%
Payout
-
Shs Outstand
3.05M
Shs Float
888.16K
-
-
-
-
Target Price
-
52W Range
40.15-141.8
52W High
-52.06%
52W Low
+69%
RSI
83.64
Rel Volume
1.83
Avg Volume
214
Volume
391
Perf Week
10.19%
Perf Month
22.35%
Perf Quarter
0.9%
Perf Half Y
15.56%
-
-
-
-
Beta
1.268
-
-
Volatility
1.99%, 6.37%
Prev Close
1.96%
Price
67.6
Change
1.96%
MASKINVEST.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.55 | 0.51 | 0.44 | 0.72 | 0.99 | |
Net income per share | 0.03 | 0.01 | 0.02 | 0.01 | 0.19 | |
Operating cash flow per share | -0.05 | 0.09 | 0.43 | -1.28 | -0.24 | |
Free cash flow per share | -0.05 | 0.09 | 0.43 | -1.28 | -0.24 | |
Cash per share | 0.1 | 0.03 | 0.1 | 0.2 | 0.08 | |
Book value per share | 21.14 | 17.25 | 60.45 | 236.41 | 316.03 | |
Tangible book value per share | 21.14 | 17.25 | 60.45 | 236.41 | 316.03 | |
Share holders equity per share | 21.14 | 17.25 | 60.45 | 236.41 | 316.03 | |
Interest debt per share | 2.54 | 2.38 | 1.89 | 2.9 | 2.49 | |
Market cap | 61.18M | 41.2M | 99.48M | 105.89M | 135.77M | |
Enterprise value | 68.61M | 48.35M | 104.94M | 114.12M | 143.24M | |
P/E ratio | 650.53 | 989.89 | 1.72K | 4.38K | 230.26 | |
Price to sales ratio | 36.43 | 26.65 | 74.44 | 48.17 | 44.03 | |
POCF ratio | -408.87 | 149.36 | 75.14 | -27.15 | -181.84 | |
PFCF ratio | -408.87 | 149.36 | 75.14 | -27.15 | -181.84 | |
P/B Ratio | 0.95 | 0.78 | 0.54 | 0.15 | 0.14 | |
PTB ratio | 0.95 | 0.78 | 0.54 | 0.15 | 0.14 | |
EV to sales | 40.85 | 31.28 | 78.53 | 51.91 | 46.45 | |
Enterprise value over EBITDA | 581.53 | 784.07 | 1.12K | 129.31 | 181.7 | |
EV to operating cash flow | -458.54 | 175.3 | 79.26 | -29.26 | -191.85 | |
EV to free cash flow | -458.54 | 175.3 | 79.26 | -29.26 | -191.85 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0.01 | 0.01 | -0.04 | -0.01 | |
Debt to equity | 0.12 | 0.14 | 0.03 | 0.01 | 0.01 | |
Debt to assets | 0.11 | 0.12 | 0.03 | 0.01 | 0.01 | |
Net debt to EBITDA | 62.99 | 116.05 | 58.49 | 9.33 | 9.48 | |
Current ratio | 1.57 | 1.63 | 1.75 | 1.47 | 1.54 | |
Interest coverage | 0 | 0 | 10.25 | 1.88K | 7.91K | |
Income quality | -1.28 | 4.48 | 16.52 | -4.42 | -0.95 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.1 | 0.13 | 0.21 | 0.11 | 0.09 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 3.83 | 2.3 | 5.07 | 6.49 | 36.76 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | -2.53 | -2.39 | -1.95 | -3.09 | -3.07 | |
Working capital | 4.55M | 4.6M | 4.66M | 4.69M | 5.27M | |
Tangible asset value | 64.5M | 52.63M | 184.47M | 721.42M | 980.72M | |
Net current asset value | 4.52M | 4.57M | 4.63M | 4.65M | 5.24M | |
Invested capital | 0.12 | 0.14 | 0.03 | 0.01 | 0.01 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 643.01K | 148.42K | 235.57K | 681.58K | 1.33M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 215.35 | 28.96 | 318.48 | 528.02 | 406.8 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 1.69 | 12.6 | 1.15 | 0.69 | 0.9 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q1
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.08 | 0.19 | 0.54 | 0.19 | 0.12 | |
Net income per share | -0.06 | 0.09 | 0.26 | -0.09 | -0.06 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0.29 | 0 | 0.08 | 0 | |
Book value per share | 0 | 332.11 | 0 | 312.97 | 0 | |
Tangible book value per share | 0 | 332.11 | 0 | 312.97 | 0 | |
Share holders equity per share | 0 | 332.11 | 0 | 312.97 | 0 | |
Interest debt per share | 0 | 2.95 | 0 | 2.46 | 0.02 | |
Market cap | 101.82M | 247.15M | 238.29M | 137.09M | 200.87M | |
Enterprise value | 101.82M | 255.01M | 238.29M | 144.57M | 200.87M | |
P/E ratio | -133.13 | 232.08 | 74.28 | -119.26 | -262.92 | |
Price to sales ratio | 393.01 | 446.17 | 143.63 | 224.43 | 521.74 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 0.25 | 0 | 0.14 | 0 | |
PTB ratio | 0 | 0.25 | 0 | 0.14 | 0 | |
EV to sales | 393.01 | 460.35 | 143.63 | 236.66 | 521.74 | |
Enterprise value over EBITDA | -398.47 | 716.76 | 222.28 | -376.81 | -1.08K | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0.01 | 0 | 0.01 | 0 | |
Debt to assets | 0 | 0.01 | 0 | 0.01 | 0 | |
Net debt to EBITDA | 0 | 22.08 | 0 | -19.48 | 0 | |
Current ratio | 0 | 1.5 | 0 | 1.54 | 0 | |
Interest coverage | 0 | 0 | 0 | -1.11K | -2.7 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 1.07 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 25.93 | 0 | 25.41 | 0 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | -2.91 | 0 | -3.04 | 0 | |
Working capital | 623.54K | 4.76M | 863.9K | 5.27M | 250.39K | |
Tangible asset value | 0 | 982.43M | 0 | 980.72M | 0 | |
Net current asset value | 623.54K | 4.73M | 863.9K | 5.24M | 250.39K | |
Invested capital | 0 | 0.01 | 0 | 0.01 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 461.57K | 350.88K | 350.88K | 863.97K | 863.97K | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 1.28K | 0 | 172.53 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0.07 | 0 | 0.52 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
MASKINVEST.NS Frequently Asked Questions
What is Mask Investments Limited stock symbol ?
Mask Investments Limited is a IN stock and trading under the symbol MASKINVEST.NS
What is Mask Investments Limited stock quote today ?
Mask Investments Limited stock price is $67.6 today.
Is Mask Investments Limited stock public?
Yes, Mask Investments Limited is a publicly traded company.